Athenex Moves Forward With $205M New York Plant Post author:Sam Post published:January 11, 2018 Post category:BioPharma According to a SEC filing, the cost of the facility will be paid in part by the State of New York. Source: BioSpace You Might Also Like This is What Amazon Can Do to Start Selling Drugs Faster November 21, 2017 Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017 Why This Bay Area Heart Software Biotech Could Become Silicon Valley’s Newest Unicorn November 30, 2017
Horizon Pharma Launches CGD Connections To Deliver Support And Resources Created By And For The Chronic Granulomatous Disease (CGD) Community July 24, 2017
Why This Bay Area Heart Software Biotech Could Become Silicon Valley’s Newest Unicorn November 30, 2017